查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1983870

靜脈注射針市場：2026-2032年全球市場預測（依產品類型、材質、規格、銷售管道、應用及最終用戶分類）

Intravenous Needles Market by Product Type, Material, Gauge, Sales Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈注射針頭市場價值將達到 22.8 億美元，到 2026 年將成長至 24.3 億美元，到 2032 年將達到 35.3 億美元，複合年成長率為 6.43%。

主要市場統計數據
基準年 2025 22.8億美元
預計年份：2026年 24.3億美元
預測年份 2032 35.3億美元
複合年成長率 (%) 6.43%

簡要概述正在重塑靜脈注射針頭市場的臨床、監管和供應鏈趨勢及其對醫療保健領導者的影響。

靜脈注射針頭仍然是現代醫療保健服務的重要組成部分，它兼顧臨床療效、病人安全和供應鏈韌性。本執行摘要整合了影響靜脈注射和輸液針頭生態系統的最重要趨勢，探討了臨床趨勢、監管壓力、材料科學、分銷演變以及對醫療服務提供者和製造商的營運影響。本文件旨在指南採購、產品開發、臨床實務和市場准入等方面的檢驗選擇。

臨床重點、材料創新和分銷管道的變化如何從根本上重新定義靜脈注射針頭的產品設計和商業化策略。

靜脈注射針領域正經歷一場變革，其驅動力源自於臨床需求、技術進步和通路創新等多面向因素的共同作用。對安全性較高的皮下注射針和輸液方案的顯著需求成長，反映了人們對職業安全、病患療效和感染控制日益成長的關注。製造商透過投資被動安全機制和一次性醫療器械，降低銳器傷和交叉感染的風險，從而更好地滿足臨床醫生的需求和醫療機構的政策要求。

2025 年美國關稅環境促使供應鏈重組、考慮近岸外包和策略採購，以維持安全和營運連續性。

2025年，美國關稅政策和貿易趨勢的變化將對整個醫療設備價值鏈的採購和製造策略提出新的考量。影響投入品和成品的關稅調整可能會影響企業在工廠位置、供應商多元化和庫存佈局方面的決策。對於依賴跨境零件、原料或成品供應的企業而言，不斷上漲的物流成本正促使它們重新評估全球企業發展，並考慮近岸外包的機會。

詳細的綜合細分分析突顯了產品、最終用戶、應用、材料、規格和銷售管道方面的差異，有助於制定有針對性的策略。

一套完善的市場區隔框架對於了解需求促進因素並根據用戶需求客製化產品系列至關重要。根據產品類型，市場可分為皮下注射針和輸液針。皮下注射針本身又包括常規注射針、胰島素注射針和安全注射針，其中安全注射針可細分為主動安全型和被動安全型。輸液針包括套針式導管和翼狀輸液針頭。套針式導管再分為中央靜脈導管和周邊靜脈導管，翼狀輸液針頭則分為可重複使用型和一次性使用型。

美洲、歐洲、中東和非洲以及亞太地區的區域因素影響著醫療設備的設計、監管合規性和市場進入策略。

區域趨勢對醫療設備的設計與選擇、監管合規性和分銷模式有顯著影響。在美洲，先進的醫院網路和不斷擴展的門診服務共同催生了臨床需求，採購方優先考慮以安全為導向的醫療設備和穩健的供應鏈連續性。此外，該地區集中化的支付系統和採購模式有利於那些能夠在大規模、高度可擴充性的產品，這促使製造商專注於經濟高效的安全解決方案和簡化的合約流程。

產業領導者如何將安全工程、在地化生產和多元化的商業模式結合，以加強其市場地位和臨床應用。

靜脈注射針頭生態系的競爭格局取決於對安全工程、卓越製造流程和多元化通路的投入。主要企業優先考慮先進的安全機制，例如減少對臨床醫生操作依賴的被動式系統，以及提升高頻操作過程中設備人體工學設計的改進。這些產品的投入通常與更完善的品管系統和更豐富的臨床證據相結合，以吸引風險規避型的醫療機構買家。

製造商、採購團隊和臨床領導者需要有針對性的營運和策略措施，以提高韌性、安全實施和市場轉換效率。

製造、採購和臨床營運部門的領導者應優先採取一套統一的措施，以應對不斷變化的靜脈注射針頭市場。首先，應使產品系列與臨床工作流程保持一致，重點強調安全至上的解決方案以及針對門診和居家醫療使用而最佳化的設計。這種一致性既能滿足必要的職業安全要求，又能促進產品在臨床環境中的應用。

為確保實際可靠性，我們採用了嚴格的混合方法研究途徑，將來自臨床醫生和採購負責人的原始資訊與監管審查和技術分析相結合。

本研究的綜合分析是基於一套系統化的方法，結合了第一手和第二手調查的調查方法，從而確保獲得可靠且可操作的見解。第一手資料包括對臨床醫生、採購經理、監管專家和醫療設備工程師的結構化訪談，這些訪談提供了關於臨床偏好、推廣障礙和營運限制的第一手觀點。除了訪談外，還與供應鏈和醫療保險報銷專家進行諮詢，以了解影響醫療設備選擇的商業性和物流因素。

整合產業趨勢和策略挑戰，強調安全第一的設計、供應鏈韌性和跨部門執行，以實現永續的臨床部署。

靜脈注射針市場正處於一個轉折點，臨床安全期望、醫療服務分散化以及供應鏈趨勢相互交織，既帶來了挑戰，也帶來了機會。採用以安全為導向、適用於門診和居家醫療環境的醫療設備和設計，對於適應不斷變化的臨床環境和降低職業風險至關重要。投資於材料創新、人性化設計和完善的品管系統的製造商，將更有能力滿足臨床醫生的需求和監管機構的要求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 靜脈注射針市場：依產品類型分類

  • 皮下注射針
    • 普通針頭
    • 胰島素針
    • 安全針
      • 主動安全
      • 被動安全
  • 點滴針
    • 針套式導管
      • 中央靜脈導管
      • 周邊導管
    • 帶翼靜脈輸液針
      • 多用途
      • 一次使用

第9章：靜脈注射針市場：依材料分類

  • 鍍鎳
  • 塑膠
    • 聚丙烯
    • PVC
  • 不銹鋼
    • 醫用級
    • 手術等級

第10章：依規格分類的靜脈注射針市場

  • 細直徑
  • 中型軌距
  • 厚規格

第11章 靜脈注射針市場：依銷售管道分類

  • 直銷
    • 醫療機構合約
    • 現場銷售
  • 銷售代理
  • 電子商務

第12章 靜脈注射針市場：依應用領域分類

  • 血液樣本
    • 微血管血液樣本採集
    • 靜脈血採樣
  • 化療
    • 鞘內給藥
    • 靜脈化療
  • 藥物管理
    • Bolus注
    • 持續靜脈輸注

第13章 靜脈注射針市場：依最終用戶分類

  • 門診治療
    • 急診中心
    • 外科中心
  • 診所
    • 診斷診所
    • 專科診所
  • 居家醫療
    • 慢性病護理
    • 術後護理
  • 醫院
    • 私立醫院
    • 公立醫院

第14章 靜脈注射針市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 靜脈注射針市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 靜脈注射針市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國靜脈注射針市場

第18章：中國靜脈注射針市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abcam Inc.
  • Advin Health Care
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomedical Srl
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Freudenberg Medical, LLC
  • Medtronic PLC
  • Merck KGaA
  • Novo Nordisk A/S
  • Olympus Corporation
  • PerkinElmer, Inc.
  • QIAGEN
  • Shimadzu Corporation
  • Siemens AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated.
  • Thermo Fisher Scientific Inc.
  • Volkmann MedizinTechnik GmbH
  • Zhejiang Longde Pharmaceutical Co., Ltd.
Product Code: MRR-F6513A06BEEA

The Intravenous Needles Market was valued at USD 2.28 billion in 2025 and is projected to grow to USD 2.43 billion in 2026, with a CAGR of 6.43%, reaching USD 3.53 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.28 billion
Estimated Year [2026] USD 2.43 billion
Forecast Year [2032] USD 3.53 billion
CAGR (%) 6.43%

A concise orientation to the clinical, regulatory, and supply chain forces reshaping intravenous needles and their implications for healthcare leaders

Intravenous needles remain a foundational element of modern healthcare delivery, intersecting clinical efficacy, patient safety, and supply chain resilience. This executive summary synthesizes the most salient dynamics shaping the intravenous and infusion needle ecosystem, examining clinical trends, regulatory pressures, materials science, distribution evolution, and the operational implications for providers and manufacturers. It is designed to inform strategic choices across procurement, product development, clinical practice, and market engagement.

The landscape of vascular access devices has shifted markedly as healthcare systems prioritize safety-engineered devices, outpatient infusion care, and home-administered therapies. Concurrently, advances in materials and design are reshaping clinician preferences and patient comfort while regulatory frameworks tighten requirements around safety mechanisms and traceability. These trends intersect with channel transformation, as e-commerce and distributor models complement institutional contracting to reach diverse end users from ambulatory centers to homecare settings.

This introduction frames the subsequent sections, which detail transformative shifts in clinical practice and market structure, analyze tariff impacts within the United States trade environment for 2025, unpack segmentation insights across product, end user, application, material, gauge, and sales channel, and provide regional and corporate perspectives. The goal is to present actionable context that leaders can apply to reduce clinical risk, strengthen procurement strategies, and prioritize innovation investments.

How converging clinical priorities, material innovations, and distribution shifts are fundamentally redefining product design and commercialization strategies for intravenous needles

The intravenous needles sector is undergoing transformative change driven by converging clinical priorities, technological advancement, and distribution innovation. A pronounced shift toward safety-engineered hypodermic needles and infusion solutions reflects heightened emphasis on occupational safety, patient outcomes, and infection control. Manufacturers that invest in passive safety mechanisms and devices engineered for single use are aligning with clinician demands and institutional policies that reduce sharps injuries and cross-contamination risks.

Simultaneously, the rise of outpatient care and home-based therapies is recalibrating product requirements. Infusion needles designed for over-the-needle catheters and winged infusion tips are being optimized for ease of use in non-hospital environments, with attention to ergonomic design, secure fixation, and simplified dressing interfaces. These changes are complemented by material innovations; the incorporation of medical-grade plastics and refined stainless-steel alloys improves device compatibility with prolonged therapies and reduces adverse interactions with drug formulations.

On the commercial side, sales channels are diversifying. Direct institutional contracting remains essential for hospitals and large networks, while distributors and e-commerce platforms expand reach into clinics, ambulatory centers, and homecare purchasers. This channel plurality demands sharper segmentation of sales approaches and supply chain elasticity. Finally, heightened regulatory scrutiny and traceability expectations are prompting manufacturers to enhance quality management systems and invest in packaging and serialization technologies to meet compliance and safety reporting needs.

The 2025 United States tariff environment prompting supply chain realignment, nearshoring considerations, and strategic sourcing to preserve safety and operational continuity

In 2025, changes to tariff policy and trade dynamics in the United States have imposed new considerations on sourcing and manufacturing strategies across the medical device value chain. Tariff adjustments affecting inputs and finished devices can influence decisions around facility placement, supplier diversification, and inventory positioning. For companies that rely on cross-border supply flows for components, raw materials, or finished goods, the increased cost of moving goods has incentivized reevaluation of global footprint and nearshoring opportunities.

These trade pressures have prompted operational leaders to assess total landed cost more rigorously, factoring in duties, logistics volatility, and customs compliance complexity. As a result, many organizations are intensifying supplier qualification processes, seeking alternative material sources that reduce tariff exposure, and negotiating long-term agreements to stabilize pricing. Regulatory teams are also working more closely with trade and legal functions to ensure classification and documentation minimize unnecessary duty burdens.

From a clinical procurement perspective, the tariff environment has accelerated collaboration between purchasing groups and clinical end users to balance cost containment with device performance and safety outcomes. Hospitals and integrated delivery networks are increasingly focused on demand forecasting accuracy and strategic stockholding policies to mitigate price and supply fluctuations. Overall, the tariff-driven environment of 2025 is accelerating supply chain modernization and strategic sourcing initiatives that prioritize resilience without compromising safety or clinical efficacy.

A detailed segmentation synthesis highlighting product, end user, application, material, gauge, and sales channel distinctions to inform targeted strategies

A nuanced segmentation framework is essential for understanding demand drivers and aligning product portfolios to user needs. Based on product type, the market divides between hypodermic needles and infusion needles. Hypodermic needles themselves encompass conventional needles, insulin needles, and safety needles, with safety needles further subdividing into active safety and passive safety options. Infusion needles include over-the-needle catheters and winged infusion tips; over-the-needle catheters differentiate into central venous catheters and peripheral catheters, while winged infusion tips are distinguished by multi use and single use configurations.

End-user segmentation captures the variety of care settings where devices are applied, spanning ambulatory, clinics, homecare, and hospitals. Ambulatory care settings can be further categorized into emergency centers and surgery centers, whereas clinics encompass diagnostic clinics and specialty clinics. Homecare demand often arises from chronic care and post operative care scenarios, and hospitals include both private and public institutions with differing procurement structures and clinical protocols.

Application-driven segmentation clarifies clinical intent and device requirements, separating use cases into blood sampling, chemotherapy, and drug administration. Blood sampling requires devices appropriate for capillary sampling or venous sampling, chemotherapy applications divide between intrathecal administration and intravenous chemotherapy, and drug administration differentiates between bolus injection and continuous infusion methodologies.

Materials-based segmentation reflects performance and compatibility priorities, differentiating nickel plated, plastic, and stainless steel options. Plastic materials include polypropylene and PVC variants, while stainless-steel distinctions are made between medical grade and surgical grade alloys. Gauge classifications-fine gauge, medium gauge, and thick gauge-affect procedure suitability and patient comfort. Sales-channel segmentation recognizes direct sales, distributors, and e-commerce as primary routes; direct sales often operate through institutional contracts and on-site sales, distributors serve retail pharmacies and wholesalers, and e-commerce spans both B2B and B2C models. Understanding these layered segments enables targeted product development, regulatory planning, and commercial strategies that align with specific clinical workflows and procurement practices.

Regional considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping device design, regulatory compliance, and go-to-market approaches

Regional dynamics exert a powerful influence on device design preferences, regulatory pathways, and distribution models. In the Americas, clinical demand is shaped by a mix of advanced hospital networks and expanding outpatient care, with purchasers placing emphasis on safety-engineered devices and robust supply chain continuity. Payment systems and procurement consolidation in this region also favor scalable products that can be standardized across large integrated delivery networks, encouraging manufacturers to focus on cost-effective safety solutions and streamlined contracting processes.

In Europe, Middle East & Africa, regulatory heterogeneity and diverse healthcare delivery settings require adaptable compliance strategies and flexible distribution partnerships. European regulatory frameworks typically demand rigorous conformity assessment, creating a market environment where traceability and quality systems are critical. In the Middle East and Africa, differing levels of healthcare infrastructure and procurement capacity make distributor relationships and localized training programs pivotal for market penetration.

Asia-Pacific presents a complex mix of mature and rapidly developing markets, driving demand for both premium, technically advanced devices and lower-cost, high-volume options. Local manufacturing capacity and government procurement policies in some markets create opportunities for partnerships and joint ventures. Across the region, the growth of outpatient and homecare services is encouraging suppliers to design devices optimized for non-hospital settings, while regulatory authorities are increasingly harmonizing standards to facilitate cross-border product movement.

Across all regions, manufacturers and suppliers must balance global quality standards with locally relevant product configurations, training, and commercialization approaches to achieve clinical adoption and supply reliability.

How industry leaders are combining safety engineering, local production, and diversified commercial models to strengthen market position and clinical adoption

Competitive dynamics in the intravenous needles ecosystem are defined by investments in safety engineering, manufacturing excellence, and channel diversification. Leading companies are prioritizing advanced safety mechanisms, including passive systems that reduce reliance on clinician activation, and refinements to device ergonomics that enhance handling during high-throughput procedures. These product investments are frequently paired with stronger quality management systems and expanded clinical evidence to support adoption among risk-averse institutional buyers.

Manufacturers are also differentiating through vertical integration and local production capacity to mitigate trade-related cost exposure and improve supply responsiveness. Strategic partnerships with contract manufacturers, material suppliers, and logistics providers enable scalable production while maintaining compliance with stringent medical device standards. In parallel, some companies are expanding service offerings-such as training, clinical support, and device management programs-to strengthen customer relationships and embed products within clinical protocols.

Commercial models are diversifying, with players investing in direct contracting capabilities for large hospital systems while simultaneously expanding distributor networks and e-commerce platforms to reach smaller clinics and homecare markets. Mergers and acquisitions remain a tactical option for acquiring complementary technologies, entering adjacent segments like catheter-based systems, or accelerating entry into high-growth care settings. Finally, firms that demonstrate proactive regulatory engagement and transparent supply chain practices tend to build stronger trust with healthcare providers and procurement professionals.

Focused operational and strategic steps for manufacturers, procurement teams, and clinical leaders to improve resilience, safety adoption, and go-to-market effectiveness

Leaders in manufacturing, procurement, and clinical operations should prioritize a cohesive set of actions to navigate the changing intravenous needles environment. First, align product portfolios to clinical workflows by emphasizing safety- engineered solutions and designs optimized for outpatient and homecare use. This alignment will support clinical adoption while addressing occupational safety imperatives.

Second, accelerate supplier diversification and onshoring where feasible to reduce exposure to tariff volatility and logistics disruption. Complement this with rigorous supplier qualification and dual-sourcing strategies that preserve product quality. Third, invest in regulatory readiness and serialization capabilities to meet evolving traceability and reporting requirements; doing so will reduce time-to-market friction and improve compliance resilience.

Fourth, tailor commercial approaches by segmenting customers across hospitals, ambulatory centers, clinics, and homecare, and design channel-specific value propositions. For large institutional buyers, bundle device supply with training and device management services; for clinics and homecare channels, focus on simplified packaging and e-commerce accessibility. Fifth, strengthen clinical evidence generation through targeted trials and real-world data collection that demonstrate safety and usability benefits, thereby supporting procurement rationales and clinician buy-in.

Implementing these recommendations requires cross-functional coordination between R&D, regulatory, supply chain, and commercial teams to translate strategic intent into operational outcomes that prioritize patient safety and market responsiveness.

A rigorous mixed-methods research approach combining primary clinician and procurement insights with regulatory review and technical analysis to ensure practical reliability

This research synthesis draws on a structured methodology that blends primary and secondary investigative approaches to ensure robust, actionable insights. Primary inputs include structured interviews with clinicians, procurement leaders, regulatory specialists, and device engineers, providing firsthand perspectives on clinical preferences, adoption barriers, and operational constraints. These interviews were complemented by advisory consultations with supply chain and reimbursement experts to understand the commercial and logistical dimensions influencing device selection.

Secondary research involved systematic review of regulatory frameworks, clinical guidelines, device standards, and published peer-reviewed literature to ground findings in authoritative sources. Product specifications, patent filings, and materials data were analyzed to identify technological trends and material innovations. Market-facing information from distributor networks, procurement consortiums, and hospital formularies informed channel and end-user dynamics.

Analytical techniques included segmentation mapping, scenario analysis to assess tariff and supply risk implications, and comparative evaluation of design features against clinical requirements. Quality assurance processes involved cross-validation of primary responses with documentary evidence and internal peer review. Ethical considerations and participant confidentiality were maintained throughout primary data collection, and all claims were corroborated by multiple sources where possible to enhance reliability.

Synthesis of sector trajectories and strategic imperatives emphasizing safety-focused design, supply resilience, and cross-functional execution for sustained clinical adoption

The intravenous needles landscape is at an inflection point where clinical safety expectations, care-delivery decentralization, and supply chain dynamics converge to create both challenges and opportunities. Embracing safety- engineered devices and designs suited to outpatient and homecare settings will be essential for aligning with evolving clinical practice and reducing occupational risk. Manufacturers that invest in materials innovation, intuitive design, and robust quality systems will be better positioned to meet clinicians' needs and regulatory scrutiny.

At the same time, supply chain resilience should be a strategic priority. Nearshoring, dual sourcing, and stronger supplier governance will help organizations manage tariff exposure and logistical volatility while preserving product quality. Commercial strategies must become more granular, balancing direct institutional engagement with distributor partnerships and digital channels to address the needs of diverse end users.

Ultimately, success in this sector will depend on cross-functional collaboration across R&D, regulatory, clinical, and commercial teams. Organizations that translate insight into targeted product offerings, evidence generation, and adaptive supply models will achieve higher rates of clinical adoption and operational continuity. The recommendations and perspectives in this summary provide a foundation for pragmatic action to improve safety outcomes and sustain market relevance in a rapidly evolving environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Needles Market, by Product Type

  • 8.1. Hypodermic Needles
    • 8.1.1. Conventional Needles
    • 8.1.2. Insulin Needles
    • 8.1.3. Safety Needles
      • 8.1.3.1. Active Safety
      • 8.1.3.2. Passive Safety
  • 8.2. Infusion Needles
    • 8.2.1. Over The Needle Catheters
      • 8.2.1.1. Central Venous Catheters
      • 8.2.1.2. Peripheral Catheters
    • 8.2.2. Winged Infusion Tips
      • 8.2.2.1. Multi Use
      • 8.2.2.2. Single Use

9. Intravenous Needles Market, by Material

  • 9.1. Nickel Plated
  • 9.2. Plastic
    • 9.2.1. Polypropylene
    • 9.2.2. PVC
  • 9.3. Stainless Steel
    • 9.3.1. Medical Grade
    • 9.3.2. Surgical Grade

10. Intravenous Needles Market, by Gauge

  • 10.1. Fine Gauge
  • 10.2. Medium Gauge
  • 10.3. Thick Gauge

11. Intravenous Needles Market, by Sales Channel

  • 11.1. Direct Sales
    • 11.1.1. Institutional Contracts
    • 11.1.2. On Site Sales
  • 11.2. Distributors
  • 11.3. E Commerce

12. Intravenous Needles Market, by Application

  • 12.1. Blood Sampling
    • 12.1.1. Capillary Sampling
    • 12.1.2. Venous Sampling
  • 12.2. Chemotherapy
    • 12.2.1. Intrathecal Administration
    • 12.2.2. Intravenous Chemotherapy
  • 12.3. Drug Administration
    • 12.3.1. Bolus Injection
    • 12.3.2. Continuous Infusion

13. Intravenous Needles Market, by End User

  • 13.1. Ambulatory
    • 13.1.1. Emergency Centers
    • 13.1.2. Surgery Centers
  • 13.2. Clinics
    • 13.2.1. Diagnostic Clinics
    • 13.2.2. Specialty Clinics
  • 13.3. Homecare
    • 13.3.1. Chronic Care
    • 13.3.2. Post Operative Care
  • 13.4. Hospitals
    • 13.4.1. Private Hospitals
    • 13.4.2. Public Hospitals

14. Intravenous Needles Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Intravenous Needles Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Intravenous Needles Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Intravenous Needles Market

18. China Intravenous Needles Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abcam Inc.
  • 19.6. Advin Health Care
  • 19.7. Argon Medical Devices, Inc.
  • 19.8. B. Braun SE
  • 19.9. Becton, Dickinson and Company
  • 19.10. Bio-Rad Laboratories, Inc.
  • 19.11. Biomedical Srl
  • 19.12. Boston Scientific Corporation
  • 19.13. Cardinal Health, Inc.
  • 19.14. Cook Group Incorporated
  • 19.15. Freudenberg Medical, LLC
  • 19.16. Medtronic PLC
  • 19.17. Merck KGaA
  • 19.18. Novo Nordisk A/S
  • 19.19. Olympus Corporation
  • 19.20. PerkinElmer, Inc.
  • 19.21. QIAGEN
  • 19.22. Shimadzu Corporation
  • 19.23. Siemens AG
  • 19.24. Smith & Nephew PLC
  • 19.25. Stryker Corporation
  • 19.26. Teleflex Incorporated.
  • 19.27. Thermo Fisher Scientific Inc.
  • 19.28. Volkmann MedizinTechnik GmbH
  • 19.29. Zhejiang Longde Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS NEEDLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVENOUS NEEDLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES INTRAVENOUS NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA INTRAVENOUS NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONVENTIONAL NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSULIN NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ACTIVE SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PASSIVE SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PERIPHERAL CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MULTI USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY NICKEL PLATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGICAL GRADE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY FINE GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY THICK GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSTITUTIONAL CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSTITUTIONAL CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INSTITUTIONAL CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ON SITE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ON SITE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY ON SITE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CAPILLARY SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY VENOUS SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRATHECAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY INTRAVENOUS CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY BOLUS INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CONTINUOUS INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY EMERGENCY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY DIAGNOSTIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY CHRONIC CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY POST OPERATIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL INTRAVENOUS NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 302. MIDDLE EAST INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 303. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY HYPODERMIC NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 306. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY SAFETY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 307. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY INFUSION NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 308. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY OVER THE NEEDLE CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY WINGED INFUSION TIPS, 2018-2032 (USD MILLION)
  • TABLE 310. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 311. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 312. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY STAINLESS STEEL, 2018-2032 (USD MILLION)
  • TABLE 313. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 314. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 316. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY BLOOD SAMPLING, 2018-2032 (USD MILLION)
  • TABLE 318. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 319. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 320. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY AMBULATORY, 2018-2032 (USD MILLION)
  • TABLE 322. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 323. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY HOMECARE, 2018-2032 (USD MILLION)
  • TABLE 324. AFRICA INTRAVENOUS NEEDLES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC INTRAVENOUS NEEDLES MARKET SIZ